Pavan Kommareddi is a dedicated biomedical researcher with a robust background in drug discovery, currently serving as the Founder and Chief Scientist at Interplay Bio. With over a decade of experience at the University of Michigan, Pavan has honed his expertise in immunology, cancer research,...
Pavan Kommareddi is a dedicated biomedical researcher with a robust background in drug discovery, currently serving as the Founder and Chief Scientist at Interplay Bio. With over a decade of experience at the University of Michigan, Pavan has honed his expertise in immunology, cancer research, and molecular biology, which he now leverages to drive innovation in drug repurposing. At Interplay Bio, he has spearheaded the development of a cutting-edge platform designed for high-throughput assays, enabling the rapid identification and validation of small molecule-disease target interactions. This pioneering work not only accelerates the drug repurposing process but also holds the potential to significantly enhance therapeutic options for patients.
Pavan's commitment to optimizing and automating research processes is evident in his approach to scaling the impact of drug discovery. By integrating advanced techniques in mammalian cell culture and biochemistry, he has successfully demonstrated the feasibility of scaling interactions that were previously constrained by traditional methodologies. His vision for Interplay Bio is to create a transformative platform that not only expedites the drug development timeline but also fosters collaboration across the biotechnology landscape.
As Pavan continues to lead Interplay Bio, he remains focused on expanding the capabilities of the platform and exploring novel applications in cell biology and phage display technologies. His passion for innovation and dedication to improving patient outcomes position him as a key player in the evolving field of biomedical research, and he is excited about the future of drug repurposing in addressing unmet medical needs.
